Clinical Trial Update: ProAlgaZyme Novel Algae Infusion: Applications in Immunodeficiency [NA]

View source ↗

Summary

This trial update notes a completed study (NCT00493506) evaluating ProAlgaZyme algae infusion for immunodeficiency, with HIV infection and Hepatitis B listed as…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• HIV Infection
• Hepatitis B

Drugs mentioned

• ProAlgaZyme

Snippet

Sponsor: Health Enhancement Products, Inc. | Conditions: HIV Infections, Hepatitis B | NA | Status: COMPLETED